Alerts will be sent to your verified email
Verify Email
VIMTALABS
|
Vimta Labs
|
Krsnaa Diagnostics
|
Nidan Labs. & Health
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.0 | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
12.43 % | 32.72 % | 7.01 % |
|
5yr average Equity Multiplier
|
1.35 | 1.71 | 2.96 |
|
5yr Average Asset Turnover Ratio
|
0.83 | 0.57 | 0.39 |
|
5yr Avg Net Profit Margin
|
10.99 % | 24.81 % | 7.86 % |
|
Price to Book
|
4.01 | 2.46 | 0.0 |
|
P/E
|
28.77 | 32.58 | 11.5 |
|
5yr Avg Cash Conversion Cycle
|
112.94 Days | -281.13 Days | -137.01 Days |
|
Inventory Days
|
26.51 Days | 8.61 Days | 2.17 Days |
|
Days Receivable
|
90.0 Days | 49.07 Days | 85.65 Days |
|
Days Payable
|
393.79 Days | 358.5 Days | 120.97 Days |
|
5yr Average Interest Coverage Ratio
|
20.28 | 9.83 | 2.01 |
|
5yr Avg ROCE
|
16.39 % | 33.72 % | 13.09 % |
|
5yr Avg Operating Profit Margin
|
26.01 % | 50.58 % | 40.06 % |
|
5 yr average Debt to Equity
|
0.12 | 0.37 | 1.91 |
|
5yr CAGR Net Profit
|
47.76 % | -19.6 % | 74.31 % |
|
5yr Average Return on Assets
|
9.41 % | 15.0 % | 2.73 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
36.92 % | 27.03 % | 57.04 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.54 % | -0.35 % | -14.18 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.49 % | 1.44 % | 0.0 |
|
Vimta Labs
|
Krsnaa Diagnostics
|
Nidan Labs. & Health
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
